This panel includes all the genes that can produce an arrhythmic phenotype (high predisposition to sudden death), whether or not associated with the presence of structural heart disease. For this reason, it includes all cardiomyopathies, channelopathies, and cardiac conduction diseases.
Approaching the genetic study with this broader panel increases the probability of finding a genetic variant in cases with a phenotype that is difficult to define in which, if a causal variant is identified, it can define the diagnosis and prognosis of the disease.
We recommend this panel in individuals with a personal history of cardiorespiratory arrest, ventricular fibrillation of undetermined origin, or a previous history of syncope with an arrhythmic profile in which findings that suggest the diagnosis of cardiomyopathy are detected.
1) Download & fill out
Please cover as many fields as possible in both documents
2) Sample collection
See sample types in the guidelines
3) Pack the sample
Please pack the sample in a way to prevent leakage
4) Send the sample & the request
Please schedule the delivery for Monday–Friday: 8am – 5pm
5) Result: the report
Via: e-mail and/or through the customer portal
"*" indicates required fields
Turnaround time (TAT): 25 days
Ref. S-201906399
Updated (dd/mm/yy): 13/03/2025
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
